No Data
No Data
The 6.2% Return This Week Takes Prestige Consumer Healthcare's (NYSE:PBH) Shareholders Five-year Gains to 92%
Some Confidence Is Lacking In Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S
Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $87
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $93
Strategic Leadership Appointment at Prestige Consumer Healthcare Boosts Growth Prospects and M&A Potential